My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 136

    1.

    Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant.

    Kelly CD, O'Loughlin C, Gelder FB, Peterson JW, Sower LE, Cirino NM.

    J Immune Based Ther Vaccines. 2007 Oct 22;5:11.PMID: 17953756 [PubMed - in process]Free PMC ArticleFree textRelated citations

    2.

    An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.

    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.

    Vaccine. 2006 May 1;24(18):3953-63. Epub 2006 Feb 28.PMID: 16530302 [PubMed - indexed for MEDLINE]Related citations

    3.

    Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.

    Sawada-Hirai R, Jiang I, Wang F, Sun SM, Nedellec R, Ruther P, Alvarez A, Millis D, Morrow PR, Kang AS.

    J Immune Based Ther Vaccines. 2004 May 12;2(1):5.PMID: 15140257 [PubMed - as supplied by publisher]Free PMC ArticleFree textRelated citations

    4.

    Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.

    Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW.

    Infect Immun. 2007 Nov;75(11):5425-33. Epub 2007 Jul 23.PMID: 17646360 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    5.

    Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.

    Herrmann JE, Wang S, Zhang C, Panchal RG, Bavari S, Lyons CR, Lovchik JA, Golding B, Shiloach J, Lu S.

    Vaccine. 2006 Jul 26;24(31-32):5872-80. Epub 2006 May 15.PMID: 16790303 [PubMed - indexed for MEDLINE]Related citations

    6.

    Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.

    Vitale L, Blanset D, Lowy I, O'Neill T, Goldstein J, Little SF, Andrews GP, Dorough G, Taylor RK, Keler T.

    Infect Immun. 2006 Oct;74(10):5840-7.PMID: 16988263 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    7.

    Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.

    Kolla RV, Chintalapati S, Sabet M, Santelli E, Liddington RC, David M, Fierer J, Guiney D, Rickert RC.

    PLoS One. 2007 Oct 17;2(10):e1044.PMID: 17940608 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    8.

    Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.

    Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP.

    Vaccine. 2006 Apr 24;24(17):3469-76. Epub 2006 Feb 21.PMID: 16519970 [PubMed - indexed for MEDLINE]Related citations

    9.

    Effective antiprotease-antibiotic treatment of experimental anthrax.

    Popov SG, Popova TG, Hopkins S, Weinstein RS, MacAfee R, Fryxell KJ, Chandhoke V, Bailey C, Alibek K.

    BMC Infect Dis. 2005 Apr 8;5(1):25.PMID: 15819985 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    10.

    Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.

    Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW Jr.

    Infect Immun. 2009 Apr;77(4):1649-63. Epub 2009 Jan 21.PMID: 19168734 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    11.

    In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.

    Staats HF, Alam SM, Scearce RM, Kirwan SM, Zhang JX, Gwinn WM, Haynes BF.

    Infect Immun. 2007 Nov;75(11):5443-52. Epub 2007 Aug 20.PMID: 17709410 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    12.

    Enhancement of the immune responses of mice to Bacillus anthracis protective antigen by CIA07 combined with alum.

    Kim SH, Park SA, Kim HK, Cho YJ, Kim KS, Kim YH, Chun JH, Lee NG.

    Arch Pharm Res. 2008 Nov;31(11):1385-92. Epub 2008 Nov 21.PMID: 19023533 [PubMed - indexed for MEDLINE]Related citations

    13.

    Activity of the Bacillus anthracis 20 kDa protective antigen component.

    Hammamieh R, Ribot WJ, Abshire TG, Jett M, Ezzell J.

    BMC Infect Dis. 2008 Sep 22;8:124.PMID: 18808698 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    14.

    Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.

    Nguyen ML, Crowe SR, Kurella S, Teryzan S, Cao B, Ballard JD, James JA, Farris AD.

    Infect Immun. 2009 Jan;77(1):162-9. Epub 2008 Nov 3.PMID: 18981257 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    15.

    Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.

    Huang J, Mikszta JA, Ferriter MS, Jiang G, Harvey NG, Dyas B, Roy CJ, Ulrich RG, Sullivan VJ.

    Hum Vaccin. 2007 May-Jun;3(3):90-3. Epub 2007 May 13.PMID: 17375001 [PubMed - indexed for MEDLINE]Related citations

    16.

    A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge.

    Klas SD, Petrie CR, Warwood SJ, Williams MS, Olds CL, Stenz JP, Cheff AM, Hinchcliffe M, Richardson C, Wimer S.

    Vaccine. 2008 Oct 9;26(43):5494-502. Epub 2008 Aug 12.PMID: 18703110 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    17.

    Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.

    Cybulski RJ Jr, Sanz P, McDaniel D, Darnell S, Bull RL, O'Brien AD.

    Vaccine. 2008 Sep 8;26(38):4927-39. Epub 2008 Jul 25.PMID: 18657585 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    18.

    Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.

    Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.

    Infect Immun. 2009 Mar;77(3):1197-207. Epub 2008 Dec 29.PMID: 19114543 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    19.

    Isolation and chimerization of a highly neutralizing antibody conferring passive protection against lethal Bacillus anthracis infection.

    Rosenfeld R, Marcus H, Ben-Arie E, Lachmi BE, Mechaly A, Reuveny S, Gat O, Mazor O, Ordentlich A.

    PLoS One. 2009 Jul 24;4(7):e6351.PMID: 19629185 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    20.

    No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.

    Baggett HC, Rhodes JC, Fridkin SK, Quinn CP, Hageman JC, Friedman CR, Dykewicz CA, Semenova VA, Romero-Steiner S, Elie CM, Jernigan JA.

    Clin Infect Dis. 2005 Oct 1;41(7):991-7. Epub 2005 Aug 29.PMID: 16142664 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk